Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women

PHASE3CompletedINTERVENTIONAL
Enrollment

515

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Nausea and Vomiting, PostoperativePostoperative Nausea and Vomiting
Interventions
DRUG

casopitant

Trial Locations (70)

1000

GSK Investigational Site, Manila

1104

GSK Investigational Site, Quezon City

1200

GSK Investigational Site, Brussels

2930

GSK Investigational Site, Brasschaat

9000

GSK Investigational Site, Ghent

9300

GSK Investigational Site, Aalst

10038

GSK Investigational Site, New York

11040

GSK Investigational Site, New Hyde Park

11501

GSK Investigational Site, Mineola

15006

GSK Investigational Site, A Coruña

15706

GSK Investigational Site, Santiago de Compostela

17036

GSK Investigational Site, Neubrandenburg

18059

GSK Investigational Site, Rostock

19055

GSK Investigational Site, Schwerin

22601

GSK Investigational Site, Winchester

22908

GSK Investigational Site, Charlottesville

23966

GSK Investigational Site, Wismar

24105

GSK Investigational Site, Kiel

27103

GSK Investigational Site, Winston-Salem

31008

GSK Investigational Site, Pamplona

32901

GSK Investigational Site, Melbourne

33067

GSK Investigational Site, Boca Raton

33143

GSK Investigational Site, Miami

33409

GSK Investigational Site, West Palm Beach

35043

GSK Investigational Site, Marburg

36106

GSK Investigational Site, Montgomery

36532

GSK Investigational Site, Fairhope

36608

GSK Investigational Site, Mobile

45208

GSK Investigational Site, Cincinnati

48073

GSK Investigational Site, Royal Oak

60637

GSK Investigational Site, Chicago

66160

GSK Investigational Site, Kansas City

66421

GSK Investigational Site, Homburg

67063

GSK Investigational Site, Ludwigshafen am Rhein

72205

GSK Investigational Site, Little Rock

73104

GSK Investigational Site, Oklahoma City

79110

GSK Investigational Site, Freiburg im Breisgau

91007

GSK Investigational Site, Arcadia

91105

GSK Investigational Site, Pasadena

91206

GSK Investigational Site, Glendale

92653

GSK Investigational Site, Laguna Hills

98195

GSK Investigational Site, Seattle

101000

GSK Investigational Site, Moscow

111538

GSK Investigational Site, Moscow

117152

GSK Investigational Site, Moscow

192242

GSK Investigational Site, Saint Petersburgh

614107

GSK Investigational Site, Perm

21229-5299

GSK Investigational Site, Baltimore

M5G 1X5

GSK Investigational Site, Toronto

M5G 2M9

GSK Investigational Site, Toronto

G1V 4G2

GSK Investigational Site, Sainte-Foy

J1H 5N4

GSK Investigational Site, Sherbrooke

625 00

GSK Investigational Site, Brno

586 01

GSK Investigational Site, Jihlava

775 20

GSK Investigational Site, Olomouc

532 03

GSK Investigational Site, Pardubice

128 51

GSK Investigational Site, Prague

150 08

GSK Investigational Site, Prague

06120

GSK Investigational Site, Halle

Unknown

GSK Investigational Site, Kwun Tong

GSK Investigational Site, Pokfulam

GSK Investigational Site, Shatin, New Territories

GSK Investigational Site, Sheung Shui, New Territories

GSK Investigational Site, Lahore

GSK Investigational Site, Bangkok

08916

GSK Investigational Site, Badalona

08003

GSK Investigational Site, Barcelona

08025

GSK Investigational Site, Barcelona

08035

GSK Investigational Site, Barcelona

08034

GSK Investigational Site, Mataró

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY